Advertisement

Topics

Pioneering Prostate Biopsy Device Awarded £789K NIHR i4i Product Development Award

05:02 EDT 3 Jul 2017 | Zyme Communications

Health Enterprise East supported medical device, CAMPROBE, picks up prestigious NHS innovation award

Cambridge, UK, 3rd July 2017 – Health Enterprise East (HEE), a leading NHS innovation hub, announced today that CAMPROBE (Cambridge Prostate Biopsy Device), a novel medical device to perform safer and more accurate prostate biopsies, has been awarded a £789,000 Invention for Innovation (i4i) Product Development Award by the National Institute for Health Research (NIHR). The pioneering device has the potential to change current standard trans-rectal prostate biopsy practice to a much safer transperineal approach in the outpatient setting, without the need for additional specialist equipment.

Dr James Clulow, Innovation Manager at HEE said: “We have been involved in the development of CAMPROBE from an early stage, and are delighted to have helped secure this significant NIHR i4i Award. It was a highly competitive process and shows how HEE works in collaboration with NHS Innovators to develop their ideas, help secure investment and ultimately, bring new technologies to patients.”
The current method of diagnosing prostate cancer is with a needle biopsy of the prostate guided by a transrectal ultrasound probe inserted into the rectum. This method carries a significant risk of side effects including urinary infections and severe sepsis as the needle traverses the bowel a number of times on the way to the prostate. The CAMPROBE will allow biopsies to be performed through the much more sterile transperineal route under local anaesthesia. In pilot trials the device resulted in no infections compared to rates of 5-12% from the current transrectal biopsy method. Moreover 8/10 men preferred the CAMPROBE approach over the current transrectal biopsy method and would recommend it to a relative or friend.

Over the next three years, the i4i Award will take CAMPROBE from a prototype through further clinical evaluation and CE marking. It is anticipated that CAMPROBE will then be ready for market launch and adoption across the NHS and be an enabling technology for a change in medical practice.

The project is being led by Mr Vincent Gnanapragasam, the consultant Urological Surgeon who first came up with the idea; it is a collaboration between Cambridge University Hospitals NHS Foundation Trust, Cambridge University, HEE, JEB Technologies and North West Anglia NHS Foundation Trust.

Commenting on the award, Mr Vincent Gnanapragasam said: “This is a fantastic opportunity to improve prostate cancer diagnostics and I am delighted that NIHR have chosen to invest in the CAMPROBE. Its use in hospital outpatient departments will mean a positive change in the experience of patients referred with suspected prostate cancer and will lead to a much safer way to diagnose the disease. This improvement will be of potential benefit to the tens of thousands of men who have prostate biopsies every year in the UK.”
For more information on HEE supported projects visit www.hee.org.uk



Mr Vincent Gnanapragasam

About Health Enterprise East www.hee.org.uk

Health Enterprise East (HEE) is a leading NHS innovation hub committed to improving healthcare through the provision of professional business and innovation management services. The HEE team works with NHS organisations nationally and Med Tech companies globally to support the development of innovative products and services which meet currently unmet healthcare needs. The company offers a broad range of tailored services from strategic analysis and market validation, to practical advice and insight.

Through its member services, HEE also ensures that pioneering innovations from staff across the NHS are identified, developed and commercialised for the benefit of patients, staff and society. Closely affiliated with founding member Papworth Hospital NHS Foundation Trust, HEE currently serves over 30 NHS organisations in the East of England, East Midlands and North London. Trusts can opt to sign up as members of HEE and access a full range of skills and expertise.

About National Institute for Health Research

The National Institute for Health Research (NIHR): improving the health and wealth of the nation through research.

Established by the Department of Health, the NIHR:

  • funds high quality research to improve health
  • trains and supports health researchers
  • provides world-class research facilities
  • works with the life sciences industry and charities to benefit all
  • involves patients and the public at every step

For further information, visit the NIHR website www.nihr.ac.uk

This project is independent research funded by the National Institute for Health Research (Invention for Innovation (i4i) Programme grant II-LB-0716-20001).

For more information please contact: Zyme Communications Sarah Jeffery E-mail: sarah.jeffery@zymecommunications.com Phone: +44 (0) 7771 730919 Health Enterprise East Chris Armstrong Email: chris.armstrong@hee.co.uk Phone: +44 (0)1223 928040 NEXT ARTICLE

More From BioPortfolio on "Pioneering Prostate Biopsy Device Awarded £789K NIHR i4i Product Development Award"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Benign Prostatic Hyperplasia (BPH)
An enlarged prostate (benign prostatic enlargement (BPE) or benign prostatic hyperplasia (BPH)) is common in men after the age of about 50. Having an enlarged prostate does not mean you have cancer. In some cases, an enlarged prostate can cause the ...